Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,244,413
-
Share change
-
-1,171,401
-
Total reported value
-
$137,742,000
-
Put/Call ratio
-
93%
-
Price per share
-
$7.55
-
Number of holders
-
42
-
Value change
-
+$2,567,714
-
Number of buys
-
20
-
Number of sells
-
19
Institutional Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q4 2019
As of 31 Dec 2019,
AVADEL PHARMACEUTICALS - COM (AVDL) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,244,413 shares.
The largest 10 holders included
BRANDES INVESTMENT PARTNERS, LP, RTW INVESTMENTS, LP, BROWN CAPITAL MANAGEMENT LLC, ACUTA CAPITAL PARTNERS, LLC, GENDELL JEFFREY L, Broadfin Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, Tekla Capital Management LLC, MORGAN STANLEY, and MILLENNIUM MANAGEMENT LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.